secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0000950170-24-008129
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus reports preliminary cash of $20.9M as of Dec 31, 2023; raised $16.8M via ATM
--------------------------------------------------------------------------------

- Raised approximately $16.8M in gross proceeds from common stock sales under Open Market Sale Agreement with Jefferies.
- Preliminary cash, cash equivalents, and investments of ~$20.9M as of Dec 31, 2023, including $13.7M in cash.
- Financial statements for year ended Dec 31, 2023 not yet finalized; amounts subject to adjustments.
- Company has not provided any revenue or earnings guidance in this update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/0000950170-24-008129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024008129/crbp-20240129.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-008129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer